CRIS | Blue Horseshoe Stocks

Blue Horseshoe Stocks: Options Review & HEMP

Options Review

We’ve placed a lot of focus on options plays this week, and thanks to the help of a solid day for the markets, we saw excellent opportunities for quick strike profits in a couple of them yesterday. Our primary order of business today is to go over the gains that have been made possible by some of our ideas.

The Netflix Inc. NFLX 01/25 $290-300 Calls were an idea we submitted in yesterday morning’s premarket report, and we saw some moderate increases in all five of those contracts, which were as follows:

$290 Calls – Range: 14.15-16.30 – Max Gain: 15%
$292.50 Calls – Range: 11.00-14.70 – Max Gain: 34%
$295 Calls – Range: 10.05-16.25 – Max Gain: 62%
$297.50 Calls – Range: 11.25-14.00 – Max Gain: 24%
$300 Calls – Range: 8.60-13.07 – Max Gain: 52%
____

We also formulated an idea for the SPDR S&P500 ETF (SPY) on Tuesday morning, the SPY Weekly $266.50-268.50 Calls, and those have flourished thanks to the bullish session for stocks in general yesterday. Here are the ranges on those contracts so far:

$266.50 Calls – Range: 1.25-3.55 – Max Gain: 184%
$267 Calls – Range: 1.02-3.20 – Max Gain: 214%
$267.50 Calls – Range: .89-2.86 – Max Gain: 221%
$268 Calls – Range: .74-2.60 – Max Gain: 251%
$268.50 Calls – Range: .66-2.28 – Max Gain: 245%

_______

Hemp, Inc. HEMP

We also wanted to make mention of HEMP, a long-time familiar play which we most recently tagged on November 30th, subsequent to which time we would observe a low of .0292.

Thanks to the passing of the farm bill in the House by a landslide, hemp and its byproducts, which includes CBD, has just been legalized at the federal level. That means big things for HEMP, and many other companies involved in CBD production and distribution. The news led to a new high of .045 for HEMP- a 54% move over our observed low from a couple of weeks ago.

Extended Watchlist:
OPTT, IPCI, BLIN, CRIS, VTL, DPW, GE, PAYX, ADIL, NBEV

Blue Horseshoe Stocks: AAPL Update & More

Apple, Inc. AAPL – Options Update

From yesterday morning’s report, we had designated a pair of Apple options contracts,
AAPL 06/01 $167.50 & $170 Calls, and as it turned out, we got a fairly decent performance out of those over the course of the day.

The $167.50’s traded up from 4.36 to hit 6.10, marking a 40% increase, and the $170’s also fared well, trading in a range from 3.30-5.00, for a bullish move of 52%

Those contracts are going to be pushed deep into the money with the gap up occurring on the heels of yesterday’s post-market earnings beat. We’ll be looking to lock in profits at the open in expectation of a dip-and-rip pattern, and if we get what we’re looking for, we will also test the waters with some other calls, the AAPL Weekly $172.50 & $175 Calls.
______

Added Post-Earnings Options Idea:
Mastercard, Inc. MA Weekly $182.50-187.50 Calls

Spectrum Global Solutions, Inc. SGSI

We were just commenting yesterday morning on how we tagged SGSI on April 25th, only to see it run from .0055 that morning, and go on to rise over 100% as it ran to a high of .012.

The stock continued to put forth opportunities yesterday, trading up in a daily range from .0082 to a new high of .0129. That works out to an intraday pop of 57% and extended our overall observed move in a week’s time to an impressive 135%

Extended Watchlist:
CRIS, FTR, SFLY, OCLR, LITE, TGOD, W

Blue Horseshoe Stocks: BABA Review & More

Alibaba Group Holding Ltd. BABA – Update

After noticing a strong double-bottom setup on the chart, we threw our hat in the ring with BABA yesterday morning by formulating an options idea to track during what we described as an overdue recovery.

The stock did exhibit the first signs of that recovery, thereby producing some nice single-session gain opportunities for ourselves and our readers. Our targeted options were the BABA 05/04 $180-187.50 Calls, and regardless of the strike price chosen within our designated range, notable able intraday profits were there for the taking.

$180 Calls – Range: 3.60-5.10 – Max Gain: 42%
$182.50 Calls – Range: 2.80-3.75 – Max Gain: 34%
$185 Calls – Range: 2.21-3.05 – Max Gain: 38%
$187.50 Calls – Range: 1.74-2.27 – Max Gain: 30%

There is, of course, plenty of time before these contracts expire, so we’ll continue monitor these ideas going forward in the event that BABA stock continues its rebounding ways. Further opportunities may arise and we’ll want to be ready.

Tandem Diabetes Care, Inc. TNDM – Update

We also wanted to update everyone on another longer term idea we formulated that has definitely worked out in our favor. We’ve had a number of stocks that we signaled our interest in earlier in 2018 slowly and steadily make monster moves for us, and TNDM is the latest one.

We initially slated this play for observation In mid-January, and after only a slight consolidation at the beginning of February, the stock established support at a low of 2.14, reversed, and began a really impressive bull run that was amplified by a significant degree yesterday. TNDM ran to a new high of 7.22. That works out to a 237% increase here in the early goings of the 2018 calendar year.

Extended Watchlist:
PVG, CRIS, EYEG, CBAY, PRPO